On the delivery of small interfering RNAs into mammalian cells

Bibliography

• FIRE A, XU S, MONTGOMERY MK, DRIVER SE, MELLO CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 391(6669):806–811.
   Google Scholar
• ••A landmark paper describing RNAi.
   Google Scholar
• JORGENSEN R: Altered gene expression in plants due to trans interaction between homologous genes. Trends Biotech. (1990) 8:340–344.
   Google Scholar
• •Excellent review describing post-transcriptional gene silencing in plants.
   Google Scholar
• HAMILTON AJ, BAULCOMBE DC: A species of small antisense RNA in posttranscriptional gene silencing in plants. Science (1999) 286:950–952.
   Google Scholar
• SEN GC: Viruses and interferons. Ann. Rev. Microbiol (2001) 55:255–281.
   Google Scholar
• ELBASHIR SM, HARBORTH J, LENDECKEL Wet al.: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 411(6830:494–498.
   Google Scholar
• ••This was the first paper to demonstrateRNAi in somatic mammalian cells.
   Google Scholar
• BARTEL DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell (2004) 116:281–297.
   Google Scholar
• SIOUD M: Therapeutic siRNAs. Trends Pharmacol Sci. (2004) 25(1):22–28.
   Google Scholar
• •A review addressing the therapeutic application of siRNAs.
   Google Scholar
• HANNON GJ, ROSSI JJ: Unlocking the potential of the human genome with RNA interference. Nature (2004) 431:371–378.
   Google Scholar
• •Excellent review addressing the potential application of RNAi.
   Google Scholar
• SIOUD M: Nucleic acid enzymes as a novel generation of antigene agents. Curr. Mol Med. (2001) 1:575–588.
   Google Scholar
• TEMPLETON NS: Liposomal delivery of nucleic acids in vivo. DNA Cell Biol. (2002) 21(12):857–867.
   Google Scholar
• KISHIDA T, ASADA H, GOJO S et al.: Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA. J. Gene. Med (2004) 6:105–10.
   Google Scholar
• LIU Y, LIGGITT D, ZHONG W et al.: Cationic liposome-mediated intravenous gene delivery. J. Biol. Chem. (1995) 270(42):24864–24870.
   Google Scholar
• MA Z, ZHANG J, ALBER S et al.: Lipid-mediated delivery of oligonucleotide to pulmonary endothelium. Am. J. Resp. Cell Mol. Biol. (2002) 27:151–159.
   Google Scholar
• BUDKER V, GUREVICH V, HAGSTROM JE et al.: pH-sensitive, cationic liposomes: a new synthetic virus-like vector. Nature Biotech. (1996) 14:760–764
   Google Scholar
• GOULA D, BECKER N, LEMKINE GF et al.: Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/ DNA complexes. Gene Ther. (2000) 7:499–504.
   Google Scholar
• SIMOES S, MOREIRA JN, FONSECA Cet al.: On the formulation of pH-sensitive liposomes with long circulation times. Adv. Drug Deliv. Rev. (2004) 56:947–965
   Google Scholar
• URBAN-KLEIN B, WERTH S, ABUHARBEID S et al.: RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. (2005) 12:461–466.
   Google Scholar
• SCHIFFELERS RM, ANSARI A, XU J et al.: Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. (2004) 32(19):e149.
   Google Scholar
• YOWELL SL, BLACKWELL S: Novel effects with polyethylene glycol modified pharmaceuticals. Cancer Treat. Rev. (2002) 28(Suppl. A):3–6.
   Google Scholar
• WOODLE MC: Controlling liposome blood clearance by surface-grafted polymers. Adv. Drug Deliv. Rev. (1998) 32:139–152.
   Google Scholar
• STEFANIDAKIS M, KOIVUNEN E: Peptide-mediated delivery of therapeutic and imaging agents into mammalian cells. Curr. Pharm. (2004) 10(24):3033–3044.
   Google Scholar
• SIMEONI F, MORRIS MC, HEITZ F, VITA G. Insight into the mechanism of the peptide-based gene system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. (2003) 31(11):2717–2724.
   Google Scholar
• VIVES E, BRODIN P, LEBLEU B: A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. (1997) 272:16010–16017.
   Google Scholar
• DEROSSI D, CALVET S, TREMBLEAU A et al.: Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol Chem. (1996) 271:18188–18193.
   Google Scholar
• MURATOVSKA A, ECCLES MR: Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett. 558:63–68.
   Google Scholar
• PUEBLA I, ESSEGHIR S, MORTLOCK A et al.: A recombinant H1 histone-based system for efficient delivery of nucleic acids. J. Biotechnol 105:215–226.
   Google Scholar
• MINAKUCHI Y, TAKESHITA F, KOSAKA N et al.: Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nud Acids Res. (2004) 32(13):e109.
   Google Scholar
• MCCAFFREY AP, MEUSE L, PHAM TT et al.: RNA interference in adult mice. Nature (2002) 418:38–39.
   Google Scholar
• •This paper describes the in vivo delivery of siRNA via high-pressure tail vein injection.
   Google Scholar
• LEWIS DL, HAGSTROM JE, LOOMIS AG et al.: Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nature Genet. (2002) 32:107–108.
   Google Scholar
• •This paper demonstrate the in vivo activity of siRNAs.
   Google Scholar
• SONG E, LEE SK, WANG J et al.: RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. (2003) 9(3):347–351.
   Google Scholar
• •This paper demonstrate the in vivo activity of siRNAs.
   Google Scholar
• ZENDER L, HUTKER S, LIEDTKE C et al.: Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl Acad. Sci. USA (2003) 100(13):7797–7802.
   Google Scholar
• SIOUD M, SORENSEN DR: Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. (2003) 312:1220–1225.
   Google Scholar
• SORENSEN DR, LEIRDAL M, SIOUD M: Gene silencing by systemic delivery of synthetic siRNAs in adult mice. Mo/. Biol. (2003) 327:761–766.
   Google Scholar
• •This paper establishes proof of principle for siRNA-based therapeutics via systemic delivery.
   Google Scholar
• VERMA UN, SURABHI RM, SCHMALTIEG A, BECERRA C, GAYNOR RB: Small interfering RNAs directed against 0-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin. Cancer Res. (2003) 9:1291–1300.
   Google Scholar
• GE Q, FILIP L, BAI A et al.: Inhibition ofinfluenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA (2004) 101(23):8676–8681.
   Google Scholar
• FLYNN MA, CASEY DG, TODRYK SM, MAHON BP: Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo. J. Infirm. (2004) 1(4):1–12.
   Google Scholar
• MUSIYENKO A. SHULYAYEVA 0, BARIK S: Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. (2005) 11(1):50–55.
   Google Scholar
• REICH SG, FOSNOT J, KUROKI A et al.: Small interfering RNA targeting VEGF effectively inhibits ocular neovascularization in a mouse model. MoL Vis. (2003) 9:210–216.
   Google Scholar
• ZHANG X, SHAN P, JIANG D et al.: Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfitsion-induced lung apoptosis. J. Biol. Chem. (2004) 279:10677–10684.
   Google Scholar
• DORN G, PATEL S, WOTHERSPOON G et al.: siRNA relieves chronic neuropathic pain. Nucleic Acids Res. (2004) 32:e49.
   Google Scholar
• AHARINEJAD S, PAULUS P, SIOUD M et al.: Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res. (2004) 64:5378–5384.
   Google Scholar
• SOUTSCHEK J, AKINC A, BRAMLAGE B et al.: Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature (2004) 432:173–178.
   Google Scholar
• •This paper demonstrates that cholesterol conjugation can improve systemic delivery of siRNAs.
   Google Scholar
• FILLEUR S, COURTIN k AIT-SI-ALI S et al.: SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombosondin-1 and slows tumor vascularization and growth. Cancer Res. (2003) 63:3919–3922.
   Google Scholar
• •A paper showing the in vivo activity of naked siRNAs.
   Google Scholar
• THAKKER DR, NATT F, HOSKEN D et al.: Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc. Nail. Acad. Sci. USA (2004) 101(49):17270–17275.
   Google Scholar
• BRAASCH DA, JENSEN S, LIU Yet al.: RNA interference in mammalian cells by chemical-modified RNA. Biochemistry (2003) 42:7967–7975.
   Google Scholar
• CHIU YL, RANA TM: siRNA function in RNAi: a chemical modification analysis. RNA (2003) 9:1034–1048.
   Google Scholar
• LAYZER JM, MCCAFFREY AP, TANNER A et al.: In vivo activity of nuclease-resistant siRNAs. RNA (2004) 10:766–771.
   Google Scholar
• •This paper describes the in vivo activity of nuclease-resistant siRNAs.
   Google Scholar
• EISTER G, TUSCHL T: Mechanisms of gene silencing by double-stranded RNA. Nature (2004) 431:343–349.
   Google Scholar
• •An up-to-date review on the mechanisms of gene silencing.
   Google Scholar
• PAROO Z, CONSTANTINESCU A et al.: Biodistribution of native and phosphorothioates siRNA. Bioorg Med. Chem. Lett. (2004) 14:1139–1143.
   Google Scholar
• BRUMMELKAMP TR, BERNARDS R, AGAMI R: A system for stable expression of short interfering RNAs in mammalian cells. Science (2002) 296:550–553.
   Google Scholar
• •The first paper describing a plasmid-based siRNA delivery in human cells.
   Google Scholar
• MIYAGISHI M, TAIRA K: U6 promoter-driven siRNA with four uridines 3'overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. BiotechnoL (2002) 19:497–500.
   Google Scholar
• LEE NS, DOHJIMA T, BAUER G et al.: Expression of small interfering RNAs targeted against HIV-I rev transcripts in human cells. Nat. BiotechnoL (2002) 20(5):500–505.
   Google Scholar
• XIA H, MAO Q, PAULSON HL, DAVIDSON BL: siRNA-mediated gene silencing in vitro and in vivo. Nat. BiotechnoL (2003) 20:1006–1010.
   Google Scholar
• ZENG Y, WAGNER EJ, CULLEN BR: Both natural and designed microRNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Molecular Cell (2002) 9:1327–33.
   Google Scholar
• ZHANG Y, BOADO RJ, PARDRIDGE WM: In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. J. Gene Med. (2003) 5:1039–1045.
   Google Scholar
• TOMAR RS, MATTA, CHAUDHARY PM: Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene (2003) 22:5712–5715.
   Google Scholar
• RUBINSON DA, DILLON CP, KWIATKOWSKI AV et al.: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. (2003) 33:401–406.
   Google Scholar
• UPRICHARD SL, BOYD B, ALTHAGE A, CHISARI FV: Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc. NatL Acad. Sci USA (2005) 102(3):773–778.
   Google Scholar
• THOMAS CE, EHRHARDT A, KAY MA: Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. (2003) 4:346–358.
   Google Scholar
• HOMMEL JD, SEARS RM, GEORGESCU D, SIMMONS D, DILEONE RJ: Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med. (2003) 9(12):1539–1544.
   Google Scholar
• XIA H, MAO Q, ELIASON SL et al.: RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med. (2004) 10:816–820.
   Google Scholar
• BRUMMELKAMP TR, BERNARDS R, AGAMI R: Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell (2002) 2:243–247.
   Google Scholar
• ANDERSON J, PAPANASTASIOU A, TAKEUCHI Y, BOSHOFF C: Inhibition primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood (2005) 105(6):2510–2518.
   Google Scholar
• MILENIC DE, BRADY ED, BRECHBIEL MW: Antibody-targeted radiation cancer therapy. Nat. Rev. Drug Discov. (2004) 3(6):488–499.
   Google Scholar
• GOSSELIN MA, LEE RJ: Folate receptor-targeted liposomes as vectors for therapeutic agents. Biotechnol Ann. Rev. (2002) 8:103–131.
   Google Scholar
• LEAMON CP, LOW PS: Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. Proc. NatL Acad. Sci. USA (1991) 88:5572–5576
   Google Scholar
• PUN SH, TACK F, BELLOCQ NC et al.: Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumour tissue by transferring-modified, cyclodextrin-based particles. Cancer Biol. Ther. (2004) 3(7):641–650.
   Google Scholar
• SHADIDI M, SIOUD M: Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells. FASEB J. (2003) 17(2):256–258.
   Google Scholar
• LORENZ C, HADWIGER P, JOHN M et al.: Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells. Bioorg-. Med. Chem. Lett. (2004) 14:4975–4977.
   Google Scholar
• EINFELS DA, SCHROEDER R, ROELVINK PW et al.: Reducing the native tropism of adenovirus vectors requires removal of both car and integrin interactions. J. ViroL 75:11284–11291
   Google Scholar
• WICKHAM TJ: Ligand-directed targetingof gene to the site of disease. Nat. Med. (2003) 9(1):135–139.
   Google Scholar
• •An excellent review addressing targeting.
   Google Scholar
• WETERING M, OVING I, MUNCAN Vet al.: Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. (2003) 4:609–615.
   Google Scholar
• •A paper addressing siRNA regulation.
   Google Scholar
• CARETTE JE, OVERMEER RM, SCHAGEN FHE et al.: Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells. Cancer Res. (2004) 64:2663–2667.
   Google Scholar
• WANG J, TEKLE E, OUBRAHIM H et al.: Stable and controllable RNA interference: investigating the physiological function of glutathionylated actin. Proc NatL Acad. Sci. USA (2003) 100:5103–5106.
   Google Scholar
• CHEN Y, STAMATOYANNOPOULOS G, SONG CZ: Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. (2003) 63:4801–4804.
   Google Scholar
• SONG J, PANG S, LU Yet al.: Gene silencing in androgen-responsive prostate cancer cells from the tissue-specific prostate- specific antigen promoter. Cancer Res. (2004) 64(1):7661–7663.
   Google Scholar
• GUPTA S, SCHOER RA, EGAN JE, HANNON GJ, MITTAL V: Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Nail. Acad. Sci. USA (2004) 101:1927–1932.
   Google Scholar
• UNWALLA HJ, LI MJ, KIM JD et al.: Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA. Nat. Biotech. (2004) 22(12):1573–1578.
   Google Scholar
• •A paper showing that Tat-inducible system can be designed.
   Google Scholar
• TISCORNIA G, GALIMI F, VERMA IM: CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc. Nail. Acad. Sci. USA (2004) 101:7347–7351.
   Google Scholar
• VENTURA A, MEISSNER A, DILLON CP et al.: Crelox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA (2004) 101:10380–10385.
   Google Scholar
• MIYAGISHI M, TAIRA K: Control of siRNA expression utilizing Cre-loxP recombination system. Nucleic Acids Res. (2003) Supp1.3: 255–256.
   Google Scholar
• JACKSON AL, BATTZ SR, SCHELTER J et al.: Expression profiling reveals off-target gene regulation by RNAi. Nat. BiotechnoL (2003) 21(6):635–637.
   Google Scholar
• •A paper describing the off-target effects of siRNAs.
   Google Scholar
• PERSENGIEV SP, ZHU X, GREEN MR: Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA (2004) 10:12–18.
   Google Scholar
• SLEDZ CA, HOLKO M, VEER MJ, SILVERMAN RH, WILLIAMS BR: Activation of the interferon system by short- interfering RNAs. Nat. Cell Biol. (2003) 5:834–839.
   Google Scholar
• •A paper describing the activation of interferon pathway by siRNAs.
   Google Scholar
• KARIKO K, BHUYAN P, CAPODICI J, WEISSMAN D: Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signalling through Toll-like receptor 3. ImmunoL (2004) 172:6545–6549.
   Google Scholar
• ALEXOPOULOU L, HOLT AC, MEDZHITOV R, FLAVELL RA: Recognition of double-stranded RNA and activation of NF-lcappaB by Toll-like receptor 3. Nature (2001) 413:732–738.
   Google Scholar
• •A paper describing the recognition of dsRNA by TLR3.
   Google Scholar
• SIOUD M: Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. MoL Bid. (2005) 348(5):1079–1090
   Google Scholar
• ••This paper shows endosomal activation ofinnate immunity genes by certain siRNA sequences.
   Google Scholar
• JUDGE AD, SOOD V, SHAW JR et al.: Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. BiotechnoL (2005) 23(4):457–462.
   Google Scholar
• ••This paper shows endosomal activation ofinnate immunity genes by certain siRNA sequences.
   Google Scholar